UK hypertension care up for review:
This article was originally published in Clinica
The UK's National Institute for Health and Clinical Excellence (NICE) is preparing to undertake a review of its guidelines on the management of hypertension. The current guidelines, issued in August 2004, included a rejection of automated ambulatory blood pressure monitoring or home monitoring devices for routine use, on the basis that "their value has not been adequately established". Current policy also emphasises the need to consider assessing cardiovascular risk, covering testing for diabetes, hypertensive damage to the heart and kidneys and secondary causes of hypertension. A preliminary review of new data will be conducted in collaboration with the British Hypertension Society, given that it too will take into account the recently-concluded Anglo-Scandinavian Cardiac Outcome Trial (ASCOT) as part of the development of its own guidelines.
You may also be interested in...
The company will use the proceeds to fund clinical trials, expand commercialization of its targeted radiation therapy, and file for CE marking in Europe.
Advanced Medical Solutions said it will buy Raleigh Adhesive Coatings for £22m ($29m) in cash to strengthen its overall wound care business.
While Amgen said the Phase III GALACTIC-HF results for omecamtiv mecarbil did not meet its high expectations for the heart failure candidate, Cytokinetics sees a path to treating certain patients.